Ming Zhang is a molecular biologist and genomics innovator with extensive experience in next-generation sequencing and translational research. She earned her Bachelor’s and PhD degrees in Molecular Biology and Biochemistry from Nankai University, focusing on disease-gene discovery and signaling pathway analysis, followed by postdoctoral training at the University of Rochester and a faculty appointment at Johns Hopkins University School of Medicine, where she obtained certification in genetics and genome analysis. She has led large-scale genomic studies across multiple disease areas and co-authored over 30 publications in leading journals. In addition to her scientific leadership, she serves as Chief Intellectual Property Officer at Complete Omics and is accredited by the USPTO as a registered patent agent, directing the strategic protection and global patent portfolio of the company’s core technologies.
At Complete Omics, I lead intellectual property strategy while supporting the advancement of the clinical omics platforms, ensuring our innovations in clinical proteomics and metabolomics are rigorously protected and positioned for long-term impact.
Co-founding Complete Omics allows me to integrate scientific insight with strategic IP stewardship, helping translate complex technologies into scalable, defensible solutions that strengthen our competitive edge and global partnerships.
Biography
Pioneering leaders in clinical proteomics, translating deep scientific innovation into robust, clinically deployable assays.
Contact Form